Federated Hermes Portfolio holdings
AUM
$53.1B
1-Year Return
30.23%
This Quarter Return
+5%
1 Year Return
+30.23%
3 Year Return
+93.51%
5 Year Return
+187.87%
10 Year Return
+487.63%
AUM
$40.3B
AUM Growth
+$535M
(+1.3%)
Cap. Flow
-$492M
Cap. Flow
% of AUM
-1.22%
Top 10 Holdings %
Top 10 Hldgs %
15.78%
Holding
2,281
New
170
Increased
711
Reduced
1,072
Closed
189
Top Buys
| 1 |
Amgen
AMGN
|
$170M |
| 2 |
LyondellBasell Industries
LYB
|
$134M |
| 3 |
AT&T
T
|
$116M |
| 4 |
Stanley Black & Decker
SWK
|
$115M |
| 5 |
Pfizer
PFE
|
$88M |
Top Sells
| 1 |
Clorox
CLX
|
$226M |
| 2 |
Broadcom
AVGO
|
$181M |
| 3 |
Gilead Sciences
GILD
|
$158M |
| 4 |
Darden Restaurants
DRI
|
$133M |
| 5 |
KeyCorp
KEY
|
$128M |
Sector Composition
| 1 | Healthcare | 20.2% |
| 2 | Technology | 14.45% |
| 3 | Financials | 10.84% |
| 4 | Industrials | 8.95% |
| 5 | Consumer Discretionary | 8.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2001
Security National Financial
SNFCA
$230M
| $1.42K | ﹤0.01% |
+185
| New | +$1.42K |
|
2002
Forestar Group
FOR
$1.46B
| $1.38K | ﹤0.01% |
61
-5,025
| -99% | -$113K |
|
2003
Valhi
VHI
$461M
| $1.34K | ﹤0.01% |
104
-3,007
| -97% | -$38.6K |
|
|
GAN
2004
DELISTED
GAN Ltd
GAN
| $1.33K | ﹤0.01% |
808
-4,889
| -86% | -$8.02K |
|
2005
Neurogene
NGNE
$285M
| $1.29K | ﹤0.01% |
78
-17
| -18% | -$281 |
|
2006
Tenable Holdings
TENB
$3.76B
| $1.26K | ﹤0.01% |
29
-24
| -45% | -$1.05K |
|
2007
Vodafone
VOD
$28.5B
| $1.26K | ﹤0.01% |
133
-3,039
| -96% | -$28.7K |
|
|
EMKR
2008
DELISTED
Emcore Corp
EMKR
| $1.25K | ﹤0.01% |
166
-46
| -22% | -$346 |
|
2009
Core Molding Technologies
CMT
$169M
| $1.23K | ﹤0.01% |
+54
| New | +$1.23K |
|
2010
Lyft
LYFT
$6.91B
| $1.22K | ﹤0.01% |
127
-619,185
| -100% | -$5.94M |
|
2011
Avista
AVA
$2.99B
| $1.22K | ﹤0.01% |
31
-5
| -14% | -$196 |
|
2012
Immuneering
IMRX
$229M
| $1.15K | ﹤0.01% |
+113
| New | +$1.15K |
|
2013
WM Technology
MAPS
$126M
| $1.13K | ﹤0.01% |
+1,354
| New | +$1.13K |
|
|
MACK
2014
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
| $1.11K | ﹤0.01% |
90
| – | – |
|
2015
C4 Therapeutics
CCCC
$194M
| $1.11K | ﹤0.01% |
402
-3,055
| -88% | -$8.41K |
|
2016
Tenaya Therapeutics
TNYA
$220M
| $974 | ﹤0.01% |
+166
| New | +$974 |
|
2017
Kimball Electronics
KE
$724M
| $967 | ﹤0.01% |
35
+9
| +35% | +$249 |
|
|
FXLV
2018
DELISTED
F45 Training Holdings Inc.
FXLV
| $930 | ﹤0.01% |
1,860
+573
| +45% | +$287 |
|
2019
Aterian
ATER
$9.76M
| $885 | ﹤0.01% |
+160
| New | +$885 |
|
2020
Curis
CRIS
$21M
| $864 | ﹤0.01% |
52
-395
| -88% | -$6.56K |
|
2021
Allogene Therapeutics
ALLO
$246M
| $845 | ﹤0.01% |
170
| – | – |
|
2022
Eos Energy Enterprises
EOSE
$2.01B
| $833 | ﹤0.01% |
+192
| New | +$833 |
|
|
IRD
2023
Opus Genetics, Inc. Common Stock
IRD
$76.1M
| $833 | ﹤0.01% |
+192
| New | +$833 |
|
2024
Talkspace
TALK
$437M
| $814 | ﹤0.01% |
641
| – | – |
|
|
HARP
2025
DELISTED
Harpoon Therapeutics, Inc. Common Stock
HARP
| $804 | ﹤0.01% |
113
-172
| -60% | -$1.22K |
|